DelMar Pharmaceuticals Announces Reverse Stock Split in Preparation for Proposed Senior Exchange Uplisting Life Science Investing
22nd Century to Make Proprietary Research Cigarettes Available Worldwide to Scientists, Researchers, and Governments Life Science Investing
Repligen Announces Pricing of $100 Million of 2.125% Convertible Senior Notes due 2021 Life Science Investing
Evoke Enters Exclusive Commercial Supply Agreement for Active Pharmaceutical Ingredient in EVK-001 Life Science Investing
Cyclacel’s Seliciclib-Sapacitabine Abstract Selected for Oral Presentation at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting Life Science Investing
Tonix Pharmaceuticals Reports Positive Topline Results from Phase 2 AtEase Study of TNX-102Â SL in Post-Traumatic Stress Disorder (PTSD) Life Science Investing
Doctors Voice Optimism About Phase 2 Trial of ProscaVax in Mexico for Prostate Cancer Life Science Investing
ITEL signs agreement with Advanced Accelerator Applications to commercialize F-18 radiopharmaceuticals in Southern Italy Life Science Investing
Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan Life Science Investing
Clarus Therapeutics Initiates Phase 3 Clinical Trial of Oral Testosterone Replacement Therapy Life Science Investing
DelMar Pharmaceuticals Announces Third Quarter Fiscal Year 2016 Financial Results Life Science Investing
